![Melissa Palmer](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Melissa Palmer
Directeur Technique/Scientifique/R&D chez CYTODYN INC.
Provenance du réseau au premier degré de Melissa Palmer
Entité | Type d'entité | Industrie | |
---|---|---|---|
16
| Public Company | Pharmaceuticals: Major | 16 |
Public Company | Pharmaceuticals: Major | 11 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Melissa Palmer via son réseau personnel
Société | Secteur | Personnes liées | Poste principal |
---|---|---|---|
SHIRE | Pharmaceuticals: Major | Director/Board Member Director/Board Member Director/Board Member Comptroller/Controller/Auditor | |
University of Oregon | College/University | Masters Business Admin Undergraduate Degree Undergraduate Degree | |
ABBOTT LABORATORIES | Medical Specialties | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
Shire Pharmaceuticals, Inc.
![]() Shire Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Shire Pharmaceuticals, Inc. manufactures pharmaceutical products. The company offers solutions for attention deficit & hyperactivity disorder, human genetic therapies, gastrointestinal, and renal diseases. The company was founded in 1986 and is headquartered in Wayne, PA | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Shire Pharmaceuticals LLC
![]() Shire Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Part of Takeda Pharmaceutical Co., Ltd., Shire Pharmaceuticals LLC is an American company that manufactures pharmaceutical products. | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
University of Pennsylvania | College/University | Doctorate Degree Doctorate Degree | |
VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Corporate Officer/Principal | |
RECKITT BENCKISER GROUP PLC | Household/Personal Care | Director/Board Member | |
Algotherapeutix SAS
![]() Algotherapeutix SAS Medical SpecialtiesHealth Technology AlgoTherapeutix SAS is a clinical-stage biotechnology company based in Suresnes, France. The French company is focused on developing targeted, first-in-class therapeutics for peripheral neuropathic pain. Its lead asset, ATX01, is a proprietary topical formulation of amitriptyline that targets the signaling pathways involved in the regulation of pain by inhibiting specific nociceptive sodium channel receptors. The company is currently recruiting patients for a phase II clinical trial of 240 patients for chemotherapy-induced neuropathic pain and a phase II proof of concept trial for erythromelalgia. AlgoTherapeutix has secured FDA fast track development status and orphan drug designation in both the US and EU. AlgoTherapeutix has raised EUR 35 million to date and has a consortium of investors, including Relyens Innovation Santé/Turenne Capital, UI Investissement, and angel investors. The company was founded in 2018 by Olivier Jean Bohuon and Stéphane Thiroloix, with Stéphane Thiroloix serving as the CEO since 2018. | Medical Specialties | Founder | |
Laboratoires Majorelle SAS
![]() Laboratoires Majorelle SAS Medical DistributorsDistribution Services Laboratoires Majorelle SAS operates as an independent French pharmaceutical company. Its products include Vitaros, Optilov, Keat range, and Carmex. The company was founded by Guillaume El Glaoui in 2012 and is headquartered in Paris, France. | Medical Distributors | Chairman | |
Essex Woodlands Management, Inc.
![]() Essex Woodlands Management, Inc. Investment ManagersFinance Essex Woodlands Management, Inc. (EW Healthcare Partners) is a private equity firm founded in 1985 by Jim L. Currie and Martin P. Sutter. The firm is headquartered in Houston, Texas. | Investment Managers | Consultant / Advisor | |
Majorelle Topco Ltd. | Director/Board Member | ||
University of London | College/University | Doctorate Degree | |
ANI PHARMACEUTICALS, INC. | Biotechnology | President | |
PAREXEL INTERNATIONAL CORPORATION | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Glaxo Group Research Ltd. | Corporate Officer/Principal | ||
Biotech Promise SCA SICAV-SIF | Director/Board Member | ||
KYMERA THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
De Montfort University | College/University | Undergraduate Degree | |
Accumulus Synergy, Inc | Founder | ||
Oregon Bioscience Association
![]() Oregon Bioscience Association Miscellaneous Commercial ServicesCommercial Services The Oregon Bioscience Association is a non-profit membership association that advocates for and promotes the growth and quality of the bioscience industry in the region. The association is based in Portland, OR. The non-profit company seeks to create opportunities for their members through advocacy, cultivation, education, and group purchasing discounts. The association is affiliated with several other organizations, including the Biotechnology Innovation Organization and the Medical Device Manufacturers Association. The bioscience industry in the region has experienced significant growth, with a bio footprint of $10.70 billion and 47,238 jobs created. | Miscellaneous Commercial Services | Chairman | |
Gurobi Optimization LLC
![]() Gurobi Optimization LLC Packaged SoftwareTechnology Services Gurobi Optimization LLC develops a suite of optimization products that exploit the mathematical, engineering and computing technologies to deliver industry-leading performance and robustness. The company was founded by Edward Rotherberg, Robert Bixby, and Zonghao Gu in 1987 and is headquartered in Houston, TX. | Packaged Software | Director of Finance/CFO | |
MolecularMD Corp.
![]() MolecularMD Corp. Medical/Nursing ServicesHealth Services MolecularMD Corp. develops and commercializes molecular diagnostics for oncology applications. Its tests are designed to assist pharmaceutical companies with selection, monitoring and management of patients treated with molecularly-targeted cancer therapies. The firm integrates gold-standard and innovative platform technologies with custom clinical assay design and validation to accelerate all phases of clinical development, including FDA approval and commercialization of in vitro companion diagnostic tests for novel anticancer agents. The company was founded by Brian Druker, Sheridan G. Snyder, and Chad D. Galderisi in 2005 and is headquartered in Portland, OR. | Medical/Nursing Services | Director of Finance/CFO | |
Foliage, Inc.
![]() Foliage, Inc. Engineering & ConstructionIndustrial Services Foliage, Inc. operates as a product development company that provides engineering and consulting services over the entire product lifecycle. It offers technology consulting, product development and engineering support services. The firm provides its services to medical and life sciences, aerospace and defense and industrial equipment industries. The company was founded by Ron Rubbico in 1991 and is headquartered in Burlington, MA. | Engineering & Construction | Chief Operating Officer | |
LEO Pharma A/S
![]() LEO Pharma A/S Pharmaceuticals: MajorHealth Technology LEO Pharma A/S develops, manufactures and markets drugs within the area of dermatology and critical care medicine. It supplies medicines to patients suffering from skin infections and diseases such as psoriasis and eczema, thrombosis, kidney disease and cancer. The company was founded by August Kongsted and Anton Antons in 1908 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chairman | |
OJB Conseil SAS | Chairman | ||
GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
Hc Bioscience, Inc.
![]() Hc Bioscience, Inc. Pharmaceuticals: MajorHealth Technology hC Bioscience, Inc. is a biotech company based in Cambridge, MA and has subsidiaries in the United States. A single trna therapy has the potential to treat many diseases, regardless of the gene or location of the mutation. hC Bioscience is dedicated to improving the lives of patients by developing first-in-class trna-based therapeutics that target protein dysfunction. The company's innovative approach to precision protein editing has the potential to treat genetically defined conditions that account for 10-15% of all human diseases. The lead platform in development is directed at restoring protein function in diseases caused by nonsense mutations or premature termination codons (PTCs). The company was founded in 2021 by Leslie J. Williams, who has been the CEO since then. | Pharmaceuticals: Major | Chairman | |
VBI Vaccines (Delaware), Inc.
![]() VBI Vaccines (Delaware), Inc. BiotechnologyHealth Technology Part of VBI Vaccines, Inc., VBI Vaccines (Delaware), Inc. develops biopharmaceuticals. Jeffrey R. Baxter has been the CEO of the American company since 2014. | Biotechnology | Director/Board Member | |
Skylark Bio, Inc.
![]() Skylark Bio, Inc. Miscellaneous Commercial ServicesCommercial Services Skylark Bio, Inc. operates as a biotechnology company. The company is based in Cambridge, MA. | Miscellaneous Commercial Services | Director/Board Member | |
SonoThera, Inc.
![]() SonoThera, Inc. Pharmaceuticals: OtherHealth Technology SonoThera, Inc. is a biotechnology company founded by Michael H. Davidson, Kenneth P. Greenberg, and Steve Feinstein. The company is based in South San Francisco, CA. The company is dedicated to treating the root cause of human disease through genetic therapy. SonoThera is developing an ultrasound-guided, nonviral gene therapy platform and treatments designed to provide patients with the next generation of safe and effective genetic medicines. The platform utilizes sonoporation, a microbubble-mediated biophysical process to non-invasively deliver genetic payloads selectively targeting a wide range of organs within the body. Kenneth P. Greenberg has been the CEO since incorporation. | Pharmaceuticals: Other | Director/Board Member | |
TFC Therapeutics, Inc.
![]() TFC Therapeutics, Inc. BiotechnologyHealth Technology TFC Therapeutics, Inc. is a biotech company based in New York, NY. TFC Therapeutics is developing novel biologics to target and eliminate key drivers of cancer recurrence and metastasis. The company is blending early-stage research with innovative platform design to develop next-generation treatments to eliminate the most resilient cancers and put an end to their recurrence before it begins. The company was founded in 2022 and Jennifer Power has been the CEO of the company since 2023. | Biotechnology | Chairman | |
BARRETT BUSINESS SERVICES, INC. | Personnel Services | Director of Finance/CFO | |
Gevity HR, Inc.
![]() Gevity HR, Inc. Personnel ServicesCommercial Services Gevity HR, Inc. provides human resources outsourced solutions. It offers payroll & payroll administration, benefits & benefits administration, risk management and loss prevention, worker's compensation & claims services as well as HR policies and procedures. The company was founded in 1993 and is headquartered in Bradenton, FL. | Personnel Services | Director of Finance/CFO | |
BOWFLEX INC. | Recreational Products | Director of Finance/CFO | |
Corporate Management Advisors, Inc. | Director of Finance/CFO | ||
Abbott Pharmaceutical, Inc. | President | ||
Académie des Technologies
![]() Académie des Technologies Academie des Technologies engages in the technology industry. The company was founded in December 2000 and is headquartered in Paris, France. | Corporate Officer/Principal | ||
University of Paris Jussieu | College/University | Doctorate Degree | |
SMITH & NEPHEW PLC | Medical Specialties | Chief Executive Officer | |
VIRBAC | Biotechnology | Director/Board Member | |
Académie nationale de Pharmacie | Corporate Officer/Principal | ||
École des Hautes Études Commerciales de Paris | College/University | Masters Business Admin | |
Pierre Fabre SA
![]() Pierre Fabre SA Pharmaceuticals: MajorHealth Technology Pierre Fabre SA is a holding company which engages in the research, development, and production of health and beauty product based on natural and biological active ingredients. It operates through the following divisions: Pharmaceutical, Consumer Health Care, and Dermo-Cosmetics. The Pharmaceutial division focuses on therapeutic products for oncology, urology, women’s health, neuropsychiatry, cardiology, pulmonology, allergology, and rheumatology. The Consumer Health division includes prescription over-the-counter drugs which covers family health, oral care, and natural health care. The Dermo-Cosmetics division comprises skin and hair care products. The company was founded by Pierre Fabre in 1962 and is headquartered in Paris, France. | Pharmaceuticals: Major | Chief Executive Officer | |
Smith & Nephew A/S (Denmark)
![]() Smith & Nephew A/S (Denmark) Medical SpecialtiesHealth Technology Smith & Nephew A/S operates as a is a global medical technology business. It specializes in healthcare, medical supplies, medical devices, wound care, orthopaedic reconstruction and sports medicine. The company was founded by Thomas James Smith in 1856 and is headquartered in Horsholm, Denmark. | Medical Specialties | Chief Executive Officer |
Statistiques
Internationale
Etats-Unis | 29 |
France | 11 |
Royaume-Uni | 9 |
Danemark | 3 |
Irlande | 2 |
Sectorielle
Health Technology | 22 |
Consumer Services | 7 |
Commercial Services | 6 |
Consumer Non-Durables | 2 |
Distribution Services | 2 |
Opérationnelle
Director/Board Member | 91 |
Corporate Officer/Principal | 37 |
Chairman | 32 |
Independent Dir/Board Member | 32 |
Director of Finance/CFO | 22 |
Relations les plus connectées
Insiders | |
---|---|
Steven Gillis | 58 |
Ian Clark | 35 |
Olivier Jean Bohuon | 24 |
Stephen Simes | 14 |
Mitchell Cohen | 12 |
Jeremy Chadwick | 11 |
Cyrus Arman | 7 |
Michael D. Mulholland | 7 |
Ryan Dunlap | 7 |
Gisele Dion | 7 |
Antonio Migliarese | 6 |
Elena Cant | 6 |
Ramy Riad | 5 |
Christopher P. Recknor | 5 |
Karen Brunke | 5 |
- Bourse
- Insiders
- Melissa Palmer
- Connexions Sociétés